檢索結果 - Andrey Rymar
- Showing 1 - 4 results of 4
-
1
Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase <i>BRAF</i> -mutant lung cancer 由 Ross A. Okimoto, Luping Lin, Victor Olivas, Elton Chan, Evan Markegard, Andrey Rymar, Dana S. Neel, Xiaohong Chen, Golzar Hemmati, Gideon Bollag, Trever G. Bivona
出版 2016Artigo -
2
Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling 由 R. P. Tripathi, Zulong Liu, Aditi Jain, Anastasia Lyon, Christina Meeks, Dana Richards, Jinpeng Liu, Daheng He, Chi Wang, Marika Nespi, Andrey Rymar, Peng Wang, Melissa Wilson, Rina Plattner
出版 2020Artigo -
3
RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling 由 Zhan Yao, Yijun Gao, Wenjing Su, Rona Yaeger, Jessica J. Tao, Na Na, Ying Zhang, Chao Zhang, Andrey Rymar, Anthony Tao, Neilawattie Merna Timaul, Rory Mcgriskin, Nathaniel A. Outmezguine, HuiYong Zhao, Qing Chang, Besnik Qeriqi, Mariano Barbacid, Elisa de Stanchina, David M. Hyman, Gideon Bollag, Neal Rosen
出版 2018Artigo -
4
Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model 由 Elizabeth E. Spangenberg, Paul Severson, Lindsay A. Hohsfield, Joshua Crapser, Jiazhong Zhang, Elizabeth A. Burton, Ying Zhang, Wayne Spevak, Jack T. Lin, Nicole Phan, Gaston Habets, Andrey Rymar, Garson Tsang, Jason Walters, Marika Nespi, Parmveer Singh, S Broome, Prabha N. Ibrahim, Chao Zhang, Gideon Bollag, Brian L. West, Kim N. Green
出版 2019Artigo
相關主題
Biology
Biochemistry
Cancer research
Cell biology
Gene
Kinase
MAPK/ERK pathway
Medicine
Melanoma
Metastatic melanoma
Mutant
Receptor
Signal transduction
Vemurafenib
Alzheimer's disease
Cancer
Cerebral amyloid angiopathy
Chemistry
Dabrafenib
Dementia
Dimer
Disease
Gene silencing
Genetics
HEK 293 cells
Hippocampus
Imatinib
Immunology
Inflammation
Lung cancer